📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Valiant Laboratories Q3 Revenue Jumps 55% YoY to ₹54.74 Cr; Net Profit Drops to ₹3.3 Lakhs
Valiant Laboratories reported a strong 55.4% YoY growth in standalone revenue from operations, reaching ₹5,474.42 Lakhs for Q3 FY26. However, net profit for the quarter plummeted to just ₹3.30 Lakhs from ₹160.01 Lakhs in the same period last year, primarily due to a sharp rise in material costs and other expenses. On a nine-month basis, the company showed a significant turnaround, posting a net profit of ₹201.54 Lakhs compared to a loss of ₹538.85 Lakhs in the previous year. The company continues to operate in a single segment of manufacturing chemicals.
Key Highlights
Revenue from operations grew 55.4% YoY to ₹5,474.42 Lakhs in Q3 FY26.
Net profit for Q3 FY26 fell sharply to ₹3.30 Lakhs from ₹160.01 Lakhs in Q3 FY25.
9M FY26 revenue doubled to ₹15,173.91 Lakhs compared to ₹7,559.16 Lakhs in 9M FY25.
Company achieved a 9M turnaround with a net profit of ₹201.54 Lakhs vs a loss of ₹538.85 Lakhs YoY.
Total expenses for the quarter rose significantly to ₹5,524.00 Lakhs, severely impacting quarterly margins.
💼 Action for Investors
Investors should closely monitor the company's ability to manage rising input costs, as the sharp drop in quarterly profit despite high revenue growth suggests significant margin pressure. While the nine-month turnaround is a positive indicator, the thin quarterly profitability warrants a cautious approach.
Valiant Lab Q3 FY26: Revenue jumps 55% to ₹54.7 Cr; Net Profit collapses to ₹3.3 Lakhs
Valiant Laboratories reported a significant 55.4% YoY increase in revenue to ₹54.74 crore for Q3 FY26. Despite the strong top-line growth, net profit collapsed to just ₹3.30 lakh, down from ₹1.60 crore in the previous year's quarter. The sharp decline in profitability is attributed to high raw material costs and increased operational expenses which nearly wiped out margins. While the nine-month performance shows a turnaround from a loss to a profit of ₹2.02 crore, the quarterly margin contraction is a major concern.
Key Highlights
Revenue from operations increased 55.4% YoY to ₹5,474.42 Lakhs in Q3 FY26.
Net profit crashed 97.9% YoY to ₹3.30 Lakhs from ₹160.01 Lakhs in the year-ago period.
Cost of materials consumed stood at ₹4,015.06 Lakhs, representing approximately 73% of total revenue.
Nine-month net profit turned positive at ₹201.54 Lakhs compared to a loss of ₹538.85 Lakhs in the previous year.
Total expenses for the quarter rose sharply to ₹5,524.00 Lakhs, nearly matching the total income of ₹5,534.93 Lakhs.
💼 Action for Investors
Investors should exercise caution as the company is struggling to translate robust revenue growth into bottom-line profits due to severe margin compression. It is advisable to monitor raw material cost trends and operational efficiency in the coming quarters before making new commitments.
Valiant Laboratories Receives ₹12.53 Crore GST Show-Cause Notice
Valiant Laboratories Limited has received a Show-Cause Cum Demand Notice from the CGST & Central Excise authorities for an aggregate amount of approximately ₹12.53 Crores. The demand includes ₹9.31 Crores for turnover mismatches during FY 2021-22 and ₹2.85 Crores for allegedly ineligible Input Tax Credit (ITC) on IPO-related expenses. Additionally, the department has raised a demand of ₹36 Lakhs regarding GST on a ₹100 Crore corporate guarantee provided to a related party. The company may also be liable for interest and penalties under the CGST Act, 2017.
Key Highlights
Total GST demand of ₹12.53 Crores issued by the Commissioner of CGST & Central Excise (Audit), Raigad.
₹9.31 Crores demand relates to turnover discrepancies between financial statements and GSTR-3B returns for FY 2021-22.
₹2.85 Crores in ITC claimed on IPO expenses deemed ineligible as they relate to exempt supplies (securities).
₹36 Lakhs demand for non-payment of GST on a ₹100 Crore corporate guarantee provided to Valiant Advanced Services Pvt Ltd.
Potential additional financial burden from interest and penalties under Sections 50, 74, and 122 of the CGST Act.
💼 Action for Investors
Investors should monitor the company's legal response to this notice and check for any future provisions made in the financial statements. The ₹12.53 Crore demand represents a significant contingent liability that could impact the company's bottom line if the outcome is unfavorable.